When Drugs Learn to Read Protein Context: What Targeted Degradation Science Means for the Future of Precision Agriculture

A landmark 2026 study published in ACS Chemical Biology has demonstrated something that should fundamentally change how we think about molecular precision — not just in medicine, but in every biological system we manage, from the human cell to the agricultural field.

The Science

Researchers at the MRC Phosphorylation & Ubiquitylation Unit at the University of Dundee, in collaboration with Harvard University and the Broad Institute of MIT and Harvard, have just published one of the most nuanced investigations yet into how targeted protein degradation (TPD) technology interacts with the full biological context of its molecular targets.

Glennie, L., Curnutt, N.M., Sathe, G., et al. (2026). The Contribution of Native Protein Complexes to Targeted Protein Degradation. ACS Chemical Biology, 21, 1095–1111. https://doi.org/10.1021/acschembio.6c00098

Targeted protein degradation is a rapidly evolving class of precision molecular tools that work by redirecting the cell's own waste-disposal machinery — the ubiquitin-proteasome system — to destroy specific proteins on command. Rather than merely inhibiting a protein the way a traditional drug might, TPD destroys it entirely, eliminating its function from the cell. The two primary TPD modalities are PROTACs (Proteolysis-Targeting Chimeras) and molecular glue degraders (MGDs) — small molecules that act as biological "matchmakers," forcing a cell's E3 ubiquitin ligase machinery to recognize and degrade a target protein it would otherwise ignore.

The clinical implications have already been validated: several lenalidomide-derived MGDs are currently in use against multiple myeloma and myelodysplastic syndromes in human patients.

Krönke, J., Fink, E.C., Hollenbach, P.W., et al. (2015). Lenalidomide induces ubiquitination and degradation of CK1α in del(5q) MDS. Nature, 523, 183–188. https://doi.org/10.1038/nature14610 (Cited directly in source paper, ref. 24 — confirmed in paper's reference list)

What the Dundee/Harvard Team Discovered

The new study focused on a critical, frequently overlooked biological reality: most proteins in living cells do not work alone. They operate as part of multi-protein complexes — molecular machines assembled from multiple subunits that collectively execute biological functions no single protein could accomplish in isolation.

The specific system studied was the serine/threonine kinase CK1α, which the eight proteins of the newly renamed SACK1 family (formerly FAM83A-H) direct to distinct subcellular locations throughout the cell. CK1α regulates WNT signaling, cell division, apoptosis, and calcium signaling — in other words, it is a master regulator with its hands in nearly every critical cellular process. Which hand it uses, and where, depends entirely on which SACK1 partner it is currently bound to.

When the research team treated cells with potent CK1α degraders (the DEG and SJ series of lenalidomide-derived compounds), they found that the degraders did not simply eliminate CK1α. They eliminated entire CK1α-SACK1 protein complexes — a phenomenon the authors describe as "bystander degradation" or "collateral damage." The molecular machinery recruited to destroy CK1α simultaneously destroyed the SACK1 partner proteins traveling with it.

This is a finding with profound implications that reach far beyond oncology.

Tsai, J.M., Nowak, R.P., Ebert, B.L., Fischer, E.S. (2024). Targeted protein degradation: from mechanisms to clinic. Nature Reviews Molecular Cell Biology, 25, 740–757. https://doi.org/10.1038/s41580-024-00729-9 (Cited directly in source paper, ref. 19 — confirmed in paper's reference list)

Why Protein Context Changes Everything

The elegance — and the challenge — of this finding is its implication that a degrader molecule does not simply destroy a target protein; it destroys a molecular ecosystem. The biological outcome depends not on the target protein in isolation, but on the full protein complex the target happens to be part of at the moment the degrader arrives.

The research team validated this principle decisively using patient-derived skin fibroblast cells from individuals with palmoplantar keratoderma (PPK), a rare skin disorder caused by a mutation in SACK1G that prevents it from binding CK1α. In these cells, the DEG-77 degrader efficiently eliminated CK1α — but left the mutant SACK1G protein untouched, precisely because the physical interaction required for codegradation was absent. Remove the protein-protein contact, and the collateral destruction stops entirely.

This is molecular context dependency at its most precise.

Glennie, L., Solà, M.C., Xunclà, M., et al. (2024). A novel FAM83G variant from palmoplantar keratoderma patient disrupts WNT signalling via loss of FAM83G-CK1α interaction. Open Biology, 14, 240075. https://doi.org/10.1098/rsob.240075 (Cited directly in source paper, ref. 14 — confirmed in paper's reference list)

The Agricultural Relevance: Precision Molecular Biology Is Coming to the Field

I want to be direct about something that I believe is underappreciated in the agricultural consulting world: the same molecular systems that make targeted protein degradation revolutionary in human medicine are present, functionally conserved, and biologically active in every plant on your farm.

The ubiquitin-proteasome system — the cellular machinery that TPD hijacks — is not a human invention. It is one of the most ancient and conserved regulatory systems in eukaryotic life. Plants use ubiquitin-mediated protein degradation to regulate virtually every critical agronomic process: hormone signaling (auxin, jasmonate, abscisic acid), pathogen defense responses, circadian rhythms controlling flowering and dormancy, drought and heat stress adaptation, and nitrogen use efficiency.

Nalawansha, D.A., Crews, C.M. (2020). PROTACs: An Emerging Therapeutic Modality in Precision Medicine. Cell Chemical Biology, 27, 998–1014. https://doi.org/10.1016/j.chembiol.2020.07.020 (Cited directly in source paper, ref. 21 — confirmed in paper's reference list)

Plant pathogens — fungi, bacteria, viruses, nematodes — have co-evolved sophisticated molecular strategies for manipulating the host plant's protein degradation machinery to suppress immune responses and establish infection. Understanding and targeting these protein-protein interactions, the same class of molecular relationships that the Dundee/Harvard team has just characterized in human cells, is an emerging frontier in plant pathology research.

The lesson from this 2026 study that most directly applies to agricultural science is this: when you target a protein, you are targeting a relationship. Molecular interventions — whether pharmaceutical compounds in a cancer patient, fungicide active ingredients on a wheat leaf, or RNA interference constructs in a biotech seed — do not act on proteins in isolation. They act on proteins embedded in complex biological contexts that determine, often unpredictably, what other molecular players are affected.

What This Means for Producers and Agricultural Businesses

The practical implications of protein complex biology for agriculture are beginning to move from research laboratories toward commercial application:

1. Next-generation biopesticides and plant defense activators

Several emerging plant health products work by targeting protein degradation pathways in pathogens or in host plant immune signaling. Understanding that these interventions can produce "bystander" effects on non-target proteins — potentially beneficial or potentially disruptive — is essential for evaluating efficacy, selectivity, and safety.

2. Precision biotech traits

Gene editing and RNAi-based crop traits that silence or modify specific proteins must account for the protein complex context of their targets. A trait designed to reduce the activity of a specific enzyme may inadvertently destabilize an entire protein complex, producing unanticipated phenotypic effects. The framework developed in the Glennie et al. study provides exactly the kind of conceptual model needed to anticipate and design around these effects.

3. Resistance mechanisms in pathogens and weeds

The Dundee/Harvard team demonstrated that loss of a single protein-protein interaction — one point mutation — was sufficient to completely protect SACK1G from codegradation even as CK1α itself was efficiently destroyed. In the context of herbicide or fungicide resistance, this type of interaction-based selectivity mechanism may explain cases where resistance arises not from changes in the target protein itself, but from disruption of the protein complex network surrounding it.

4. Microbiome and rhizosphere protein biology

Soil microorganisms — mycorrhizal fungi, nitrogen-fixing bacteria, plant growth-promoting rhizobacteria — interact with plant roots through molecular interfaces that are increasingly understood to involve protein-protein recognition and ubiquitin-mediated signaling. Agronomic practices that alter soil biology are, at a molecular level, altering the protein-complex landscape of the rhizosphere.

The Broader Principle: Context Is Everything

The central message of this research — that the biological effect of any molecular intervention depends critically on the protein complex context of its target — is one that resonates far beyond the cancer biology laboratory. It is a principle that applies equally to every molecular tool we deploy in agricultural systems: fungicides, herbicides, insecticides, plant growth regulators, biocontrol agents, and precision biotech traits.

The field of agricultural science has always recognized that soil health, climate, and management history create the context within which individual inputs perform. The molecular biology research coming out of institutions like the MRC-PPU at Dundee, Harvard, and the Broad Institute is now telling us that the same is true at the sub-cellular level: the protein complex context of a molecular target shapes every biological outcome.

At Higher Ground Plant Consulting, this is precisely the kind of science we track — not because every producer needs to understand ubiquitin ligase biology, but because the principles it reveals have direct implications for how we think about plant performance, stress responses, pathogen interactions, and the precision tools that will define the next generation of agricultural management.

Ready to Think More Precisely About Your Operation?

At Higher Ground Plant Consulting LLC, Dr. Brian C. King, PhD (Crop Science), MBA, brings over 20 years of experience translating frontier plant and agricultural science into practical consulting insights for producers and agribusiness professionals.

Whether you are evaluating new crop protection chemistry, designing a precision agronomy program, or thinking through the biological underpinnings of your production system, we are here to help you operate with greater scientific clarity and confidence.

📧 dr.king@highergroundplantconsulting.com 🌐 www.highergroundplantconsulting.com 📞 859-536-8544

Science-based. Field-proven. Kentucky-rooted.